Table 1 Backgrounds, laboratory data, outcome of patients hospitalized with COVID-19

Backgrounds

Age (y)

71.8

61.8

0.173

Male n (%)

3 (60)

4 (67)

 > 0.999

BMI (kg/m²)

23.0

24.5

0.716

Dialysis vintage (y)

6.2

7.7

0.646

Causes of ESRD n (%)

DM

4 (80)

1 (17)

0.103

Sclerosis

1 (20)

4 (67)

MN

0 (0)

1 (17)

Smoke n (%)

2 (40)

4 (67)

0.567

Comorbidity n (%)

DM

4 (80)

1 (17)

0.036

Hypertension

3 (60)

6 (100)

0.182

Hyperlipidemia

0 (0)

3 (50)

0.182

Cardiovascular disease

3 (60)

3 (50)

 > 0.999

Lung disease

1 (20)

0 (0)

0.455

Malignant tumor

2 (40)

1 (17)

0.546

Laboratory data on admission (min-max)

Alb (g/dL)

2.92 (2.3–3.4)

3.25 (2.7–3.7)

0.305

LDH (U/L)

316.4 (201–445)

261.0 (164–376)

0.398

CRP (mg/dL)

10.85 (0.43–20.03)

7.47 (0.00–22.10)

0.502

Ferritin (ng/mL)

1027.8 (112–2508)

256.3 (38–518)

0.429

Lymphocyte count (/μL)

521.9 (91–924)

776.3 (265–1245)

0.247

D-dimer (μg/mL)

3.28 (1.3–8.8)

1.48 (1.1–2.2)

0.113

Laboratory data 7 days after admission (min-max)

Alb (g/dL)

2.3 (1.9–2.7)

2.9 (2.3–3.2)

0.026

LDH (U/L)

489.6 (312–903)

224.2 (156–276)

0.004

CRP (mg/dL)

7.53 (2.28–24.5)

1.52 (0.51–2.39)

0.082

Ferritin (ng/mL)

749.6 (104–2131)

262.0 (105–552)

0.329

Lymphocyte count (/μL)

513.5 (304–864)

732.2 (414–1001)

0.126

D-dimer (μg/mL)

3.8 (1.3–10.2)

2.0 (0.9–5.5)

0.178

Outcome n (%)

Treatment complications

2 (40)

2 (33)

 > 0.999

Severity

Severe

1 (20)

6 (100)

0.006

Critical

4 (80)

0 (0)

HFNC, Intubate

4 (80)

0 (0)

0.006

Survive

2 (40)

6 (100)

0.026